about
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection ModelZika crisis in Brazil: challenges in research and developmentDengue virus requires the CC-chemokine receptor CCR5 for replication and infection developmentExploring the Homeostatic and Sensory Roles of the Immune SystemHydrocephalus and arthrogryposis in an immunocompetent mouse model of ZIKA teratogeny: A developmental studyN-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionDevelopment of a model of Saint Louis encephalitis infection and disease in mice.Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice.Isolation of saint louis encephalitis virus from a horse with neurological disease in Brazil.A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.Targeting CCL5 in inflammation.Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus.IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.First genome sequence of St. Louis encephalitis virus (SLEV) isolated from a human in Brazil.Host target-based approaches against arboviral diseases.Zika-virus-infected human full-term placental explants display pro-inflammatory responses and undergo apoptosis.Biological and social challenges of human reproduction in a long-term Mars baseDengueInterleukin-33 contributes to disease severity in Dengue virus infection in miceA yellow fever-Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in miceA Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing AntibodiesShielding and stealth effects of zwitterion moieties in double-functionalized silica nanoparticles
P50
Q23309956-86416939-1575-429F-986A-EBECCD86003EQ24261398-34D47655-A6D0-44E1-A366-5B74BB180AF9Q26700116-C4F2E7D0-F22B-4570-AA2A-678FF3C6014BQ26750366-FFB32031-CD58-4552-A8E8-B405CA9C19FEQ28833079-5615C971-53C4-4195-9968-86E30F747F09Q30145688-39B027A1-4ACD-4FE0-B7FA-2AAE4DD5DCF3Q30842619-AD9A53BC-BA43-4F38-8891-B214C878D8ADQ33393510-1B6FE277-86E1-40FC-BCA9-8E69102E1484Q35054183-D514FF54-8A59-4933-8656-BD501BD605D3Q35235639-26609A41-3B7D-4B46-B3DA-E593586D97B1Q38148785-BD2918E9-83A3-44AA-8509-AE1A46D21772Q38722300-265BB183-C521-4E2B-B52E-E186DEFFA359Q39034933-A34469F9-1F52-4304-9EA9-C2B395EBA78DQ40166808-55CFC0E5-24A7-4198-BC70-A20B118A934FQ44169948-5BB463E6-3E42-44E6-8C53-9F2649AA9FE1Q55084390-488AE73F-3DE3-4166-B2CE-3E5F85BE374AQ56422308-45451660-D5DF-4DFA-AE90-200B624B2F0CQ56422387-9DD022A9-969C-438A-B6A2-55C4E94B97F9Q59354754-CF9D7F61-8EED-47BE-AF4D-6B434B57E7D3Q60031597-CE70A1D2-A512-4B1F-933F-DF5BFC3E42A6Q91707686-DCDAB32E-A1F5-432E-9B3A-E1607B06E23EQ92988052-3726C0BF-18A7-480A-9319-887671BF18A4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Rafael Elias Marques
@af
Rafael Elias Marques
@an
Rafael Elias Marques
@ast
Rafael Elias Marques
@bar
Rafael Elias Marques
@br
Rafael Elias Marques
@ca
Rafael Elias Marques
@co
Rafael Elias Marques
@cs
Rafael Elias Marques
@cy
Rafael Elias Marques
@da
type
label
Rafael Elias Marques
@af
Rafael Elias Marques
@an
Rafael Elias Marques
@ast
Rafael Elias Marques
@bar
Rafael Elias Marques
@br
Rafael Elias Marques
@ca
Rafael Elias Marques
@co
Rafael Elias Marques
@cs
Rafael Elias Marques
@cy
Rafael Elias Marques
@da
altLabel
Rafael E Marques
@en
prefLabel
Rafael Elias Marques
@af
Rafael Elias Marques
@an
Rafael Elias Marques
@ast
Rafael Elias Marques
@bar
Rafael Elias Marques
@br
Rafael Elias Marques
@ca
Rafael Elias Marques
@co
Rafael Elias Marques
@cs
Rafael Elias Marques
@cy
Rafael Elias Marques
@da
P214
P244
P1053
R-4890-2016
P106
P1153
37085380300
P21
P214
P244
n2014188470
P2798
P31
P3829
P3835
rafael-elias-marques
P496
0000-0002-6949-0947
P734
P7859
lccn-n2014188470